Zhang Y - Search Results

1

Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma.

Zhao L, Yang Y, Ma B, Li W, Li T, Han L, Zhang Y, Shang YM, Lin H, Gao Q. Zhao L, et al. Among authors: zhang y. J Oncol. 2019 Sep 26;2019:6454989. doi: 10.1155/2019/6454989. eCollection 2019. J Oncol. 2019. PMID: 31662753 Free PMC article.

2

Sintilimab maintenance therapy post first-line cytokine-induced killer cells plus chemotherapy for extensive-stage small cell lung cancer.

Ma B, Zhou Y, Shang Y, Zhang Y, Xu B, Fu X, Guo J, Yang Y, Zhang F, Zhou M, Huang H, Li F, Lin H, Zhao L, Wang Z, Gao Q. Ma B, et al. Among authors: zhang f, zhang y. Front Oncol. 2022 Sep 9;12:852885. doi: 10.3389/fonc.2022.852885. eCollection 2022. Front Oncol. 2022. PMID: 36158690 Free PMC article.

3

Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in metastatic brain tumor patients.

Li W, Wang Y, Zhao L, Xu L, Zhang Y, Mai L, Gao Q. Li W, et al. Among authors: zhang y. Oncol Res Treat. 2015;38(4):160-5. doi: 10.1159/000380890. Epub 2015 Mar 16. Oncol Res Treat. 2015. PMID: 25877939 Clinical Trial.

4

Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review.

Zhang Y, Song Y, Gao Q. Zhang Y, et al. Oncol Lett. 2015 Aug;10(2):883-886. doi: 10.3892/ol.2015.3296. Epub 2015 May 29. Oncol Lett. 2015. PMID: 26622588 Free PMC article.

5

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.

Wang Z, Liu Y, Li R, Shang Y, Zhang Y, Zhao L, Li W, Yang Y, Zhang X, Yang T, Nie C, Han F, Liu Y, Luo S, Gao Q, Song Y. Wang Z, et al. Among authors: zhang x, zhang y. J Hematol Oncol. 2016 Feb 3;9:6. doi: 10.1186/s13045-016-0237-6. J Hematol Oncol. 2016. PMID: 26842696 Free PMC article.

6

Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinoma.

Zhao L, Li W, Wang Z, Yang Y, Zhang Y, Shang Y, Ren X, Gao Q. Zhao L, et al. Among authors: zhang y. Immunotherapy. 2018 Mar 1;10(6):501-510. doi: 10.2217/imt-2017-0140. Immunotherapy. 2018. PMID: 29562855

7

Efficacy and safety of trastuzumab as maintenance or palliative therapy in advanced HER2-positive gastric cancer.

Fu X, Zhang Y, Yang J, Qi Y, Ming Y, Sun M, Shang Y, Yang Y, Zhu X, Gao Q. Fu X, et al. Among authors: zhang y. Onco Targets Ther. 2018 Sep 20;11:6091-6100. doi: 10.2147/OTT.S174138. eCollection 2018. Onco Targets Ther. 2018. PMID: 30275713 Free PMC article.

8

Combination of PD-1 blockade and RetroNectin^®-activated cytokine-induced killer in preheavily treated non-small-cell lung cancer: a retrospective study.

Zhao L, Han L, Zhang Y, Li T, Yang Y, Li W, Shang Y, Lin H, Gao Q. Zhao L, et al. Among authors: zhang y. Immunotherapy. 2018 Nov;10(15):1315-1323. doi: 10.2217/imt-2018-0125. Epub 2018 Oct 23. Immunotherapy. 2018. PMID: 30350739

9

A study of the clinical characteristics and prognosis of advanced mucosal and cutaneous melanoma in a Chinese population.

Zhang Y, Fu X, Qi Y, Gao Q. Zhang Y, et al. Immunotherapy. 2019 Feb;11(2):91-99. doi: 10.2217/imt-2018-0030. Epub 2018 Dec 4. Immunotherapy. 2019. PMID: 30511592

10

Clinical value of neutrophil-to-lymphocyte ratio as a predictor of prognosis of RetroNectin^®-activated cytokine-induced killer cell therapy in advanced non-small-cell lung cancer.

Zhao L, Li T, Yang Y, Zhang Y, Li W, Han L, Shang Y, Lin H, Ren X, Gao Q. Zhao L, et al. Among authors: zhang y. Immunotherapy. 2019 Mar;11(4):273-282. doi: 10.2217/imt-2018-0147. Epub 2018 Dec 14. Immunotherapy. 2019. PMID: 30547699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256,575 results

Search Page

Filters